We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Turn-Key PCR Solution Enables On-Site, Near Patient Testing for Monkeypox Virus

By LabMedica International staff writers
Posted on 30 Jun 2022

The World Health Organization has reported that over 2,100 people in 42 countries have been diagnosed with Monkeypox as of June 15, nearly all during the past two months. This makes it important for healthcare providers worldwide to have a preparedness plan. Now, a turn-key PCR solution for testing Monkeypox is designed to be carry out on-site, near patient, thus avoiding the need to transport patient samples to central labs for testing.

The CE-marked portable solution from Anitoa Systems (Sunnyvale, CA, USA) includes one of a family small foot-print real time PCR instruments called the Maverick qPCR, with an extraction-free multiplex PCR reagent that tests OPXV/MPXV gene-targets in the skin lesion sample from patients suspected of infection with Monkeypox. Anitoa's Maverick line of multiplex real time PCR devices are lab-accurate, fast, portable and calibration-free. They can operate on battery power (including car battery) and takes up very little bench space.


Image: DNA test for Monkeypox (Photo courtesy of Anitoa Systems)
Image: DNA test for Monkeypox (Photo courtesy of Anitoa Systems)

Maverick qPCR instruments are built on Anitoa's proprietary CMOS biosensor technology. They have been used widely for on-site testing of food, environment samples and agriculture products due to its rugged all solid-state design, small form factor, and lower operation cost. Already having a presence in Africa, Anitoa has begun deploying its near-patient Monkeypox test in selected clinics in Africa and is prepared to deliver its Monkeypox test solution world-wide when the need arises. Anitoa's Monkeypox detection solution is part of an on-going program at the company to develop tests to help combat a series of neglected tropical diseases in low resource settings. These tests currently include IVDR tests for Dengue, Yellow Fever, and Malaria

"We are closely monitoring the situation of Monkeypox infections around the world and tailoring our test solutions to the needs of the people affected," said Zhimin ding, CEO of Anitoa Systems, LLC.

Related Links:
Anitoa Systems


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Latest Molecular Diagnostics News

Blood Samples Enhance B-Cell Lymphoma Diagnostics and Prognosis

Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans